Litcius/Paper detail

Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients

Yu Feng, Le Tang, Hongyu Wang, Yutao Liu, Sheng Yang, Lin Lin, Xingsheng Hu, Yuankai Shi

2022Cancer Immunology Immunotherapy15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineAdenocarcinomaGastroenterologyClinical endpointLung cancerBevacizumabAdverse effectOncologyApatinibProgression-free survivalSurgeryChemotherapyCancerClinical trialLung Cancer Research StudiesCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Immune checkpoint inhibitors combined with angiogenic inhibitors in the treatment of locally advanced or metastatic lung adenocarcinoma patients | Litcius